Intellectual Property Protection

Zensun Sci & Tech Co., Ltd. is an international biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products.  Intellectual property protection is of great importance to the innovation. Zensun cooperates with Jones Day, a famous American law firm which has the largest intellectual property protection lawyers team, to file and maintain its patents in past years. Until March 2018, 183 patents have been applied, and 81 of them have been issued including 78 innovation patents. The protection of patents covers China, U.S., Japan, Europe, Russia, Australia and other major biopharmaceutical market regions. Take company’s core product Neuregulin as an example, Zensun’s intellectual property protection not only protects the application of Neuregulin polypeptide or its composition in chronic heart failure (CHF), myocardial infarction (MI), viral myocarditis (VMC), dilated cardiomyopathy (DCM) as well as heart failure caused by the heart diseases mentioned above, but also includes effective dose, method of administration, target patients, diagnosis methods, and formulation. Zensun has built the most sound and effective intellectual property protection system in multi-perspectives and multi-levels.

陈炽：专利律师

中国科技大学细胞生物学学士，哈佛大学法学博士，美国众达（Jonesday）律师事务所合伙人，上海市浦东新区政府生物医药产业高级顾问。他在海外拥有多年代理高科技和生物技术公司知识产权事务的经验，代理中国企业全球范围的专利事务和国际知识产权纠纷。自2005年4月以来，陈博士一直为泽生提供专利及其他法律事务方面的服务。